Want to see HK:2293 full AI Analyst Report?
Top Page
Bamboos Health Care Holdings Ltd
(2293)
Select Model
Select Model
Rating:64Neutral
Price Target:
HK$0.41
▼(-17.60% Downside)
Action:Reiterated
Date:07/08/26
The score is driven primarily by mixed financial performance: strong current profitability and a conservative balance sheet are offset by declining revenue since 2022, margin/ROE deterioration, and less convincing cash-flow quality versus earlier years. Valuation is a positive (moderate P/E and high yield), but technical indicators remain weak with negative MACD and price below key moving averages.
Positive Factors
Conservative balance sheet
Modest debt-to-equity (≈0.27–0.33) and a conservatively positioned balance sheet provide a durable financial cushion. This reduces refinancing and solvency risk, supports operations through cycles, and leaves capacity to fund opportunistic investments or sustain distributions over the medium term.
Negative Factors
Declining revenue trend
A multi-year top-line decline culminating in ~-13% in 2025 signals loss of scale and demand headwinds. Persistent revenue contraction reduces margin leverage, limits reinvestment capacity, and raises risk to earnings and dividend sustainability if the trend continues over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Modest debt-to-equity (≈0.27–0.33) and a conservatively positioned balance sheet provide a durable financial cushion. This reduces refinancing and solvency risk, supports operations through cycles, and leaves capacity to fund opportunistic investments or sustain distributions over the medium term.
Read all positive factors
Bamboos Health Care Holdings Ltd (2293) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$154.95M
Dividend Yield10.39%
Average Volume (3M)47.07K
Price to Earnings (P/E)9.2
Beta (1Y)0.16
Revenue Growth-17.36%
EPS Growth-29.80%
CountryHK
Employees75
SectorIndustrials
Sector Strength72
IndustryStaffing & Employment Services
Share Statistics
EPS (TTM)0.04
Shares Outstanding402,460,000
10 Day Avg. Volume20,400
30 Day Avg. Volume47,066
Financial Highlights & Ratios
PEG Ratio-0.26
Price to Book (P/B)0.87
Price to Sales (P/S)2.69
P/FCF Ratio5.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bamboos Health Care Holdings Ltd Business Overview & Revenue Model
Company Description
Bamboos Health Care Holdings Limited functions as an investment holding entity primarily dedicated to furnishing healthcare workforce solutions throughout Hong Kong. Its extensive array of services includes vital support for medical facilities and...
How the Company Makes Money
null...
Bamboos Health Care Holdings Ltd Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
78
Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 69.88M | 74.40M | 94.79M | 126.56M | 140.29M | 109.67M |
| Gross Profit | 25.87M | 31.00M | 84.72M | 115.12M | 91.33M | 82.19M |
| EBITDA | 27.41M | 34.98M | 52.76M | 69.85M | 81.32M | 78.05M |
| Net Income | 16.72M | 17.54M | 30.92M | 46.92M | 58.62M | 61.02M |
Balance Sheet | ||||||
| Total Assets | 335.25M | 315.90M | 318.06M | 346.83M | 351.35M | 240.84M |
| Cash, Cash Equivalents and Short-Term Investments | 39.20M | 52.96M | 81.15M | 93.27M | 86.27M | 98.31M |
| Total Debt | 60.94M | 62.13M | 63.73M | 68.24M | 68.96M | 3.31M |
| Total Liabilities | 81.20M | 86.54M | 99.74M | 124.51M | 140.75M | 46.05M |
| Stockholders Equity | 254.05M | 229.36M | 218.33M | 222.32M | 210.60M | 194.79M |
Cash Flow | ||||||
| Free Cash Flow | 6.92M | 35.03M | 35.75M | 41.67M | 100.37M | 49.42M |
| Operating Cash Flow | 26.15M | 36.84M | 37.41M | 41.94M | 116.11M | 49.44M |
| Investing Cash Flow | -48.78M | -51.58M | -7.09M | 6.92M | -111.63M | -71.38M |
| Financing Cash Flow | -18.21M | -22.82M | -42.44M | -41.80M | 25.15M | -23.04M |
Bamboos Health Care Holdings Ltd Technical Analysis
Positive
0.50
Price Trends
0.37
Positive
0.38
Negative
0.43
Negative
Market Momentum
<0.01
Negative
63.15
Neutral
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2293, the sentiment is Positive. The current price of 0.5 is above the 20-day moving average (MA) of 0.37, above the 50-day MA of 0.37, and above the 200-day MA of 0.43, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 63.15 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2293.
Bamboos Health Care Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$336.40M | 10.27 | 4.28% | 7.86% | -2.78% | -24.77% | |
64 Neutral | HK$154.95M | 9.23 | 6.92% | 10.39% | -17.36% | -29.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | HK$1.03B | 31.32 | 1.27% | ― | ― | ― | |
40 Underperform | HK$64.62M | 4.05 | 12.17% | ― | 36.68% | ― | |
40 Underperform | HK$1.19B | 82.86 | 0.48% | 1.03% | -3.26% | ― | |
33 Underperform | HK$48.01M | 1,210.00 | 0.90% | 7.69% | 6.13% | ― |
* Industrials Sector Average
HK:2293
Bamboos Health Care Holdings Ltd
0.39
-0.16
-28.70%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.11
<0.01
0.88%
HK:3886
Town Health International Medical Group Ltd.
0.17
-0.08
-32.30%
HK:6639
Arrail Group Ltd.
1.83
-0.40
-17.98%
HK:0722
UMP Healthcare Holdings Limited
0.42
-0.03
-6.04%
HK:8307
Medicskin Holdings Ltd.
0.12
-0.10
-45.00%
Bamboos Health Care Holdings Ltd Corporate Events
Bamboos Health Care Announces Resignation of Executive Director
May 22, 2026
Bamboos Health Care Holdings Ltd has announced that executive director Mr. Cheng Sau Kong will resign from the board with effect from 22 May 2026. The company said Mr. Cheng is stepping down to focus on other engagements and business commitments, ...
Bamboos Health Care Revamps Board and Committee Roles Effective May 2026
May 22, 2026
Bamboos Health Care Holdings Limited has updated the composition of its board of directors effective 22 May 2026, confirming Ms. Hai Hiu Chu as executive director, chairman and chief executive officer, supported by three independent non-executive ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.